Drug Profile


Alternative Names: Atelec; Cinalong; FRC 8653; FRG 8653; Siscard Tablets

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator UCB Japan
  • Developer Ajinomoto; UCB Japan
  • Class Antihypertensives; Dihydropyridines
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Hypertension

Most Recent Events

  • 01 Jan 2005 Cilnidipine has been licensed to Kissei in Japan
  • 02 Oct 2003 A clinical study has been added to the adverse events and Hypertension pharmacodynamics sections
  • 14 Jun 2001 Three studies have been added to the pharmacodynamics section ,,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top